BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15528423)

  • 1. Cancer research. Inflammation and cancer: the link grows stronger.
    Marx J
    Science; 2004 Nov; 306(5698):966-8. PubMed ID: 15528423
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer related inflammation: the macrophage connection.
    Sica A; Allavena P; Mantovani A
    Cancer Lett; 2008 Aug; 267(2):204-15. PubMed ID: 18448242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new mechanism of COX-2 in inflammation].
    Sano H
    Ryumachi; 2002 Jun; 42(3):560-72. PubMed ID: 12166110
    [No Abstract]   [Full Text] [Related]  

  • 4. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex.
    Zhang X; Dong F; Ren J; Driscoll MJ; Culver B
    Exp Neurol; 2005 Feb; 191(2):318-25. PubMed ID: 15649487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin.
    Sclabas GM; Uwagawa T; Schmidt C; Hess KR; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2005 Jun; 103(12):2485-90. PubMed ID: 15861417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cyclooxygenase-2 the alpha and the omega in cancer?
    Prescott SM
    J Clin Invest; 2000 Jun; 105(11):1511-3. PubMed ID: 10841506
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus self-improvement through inflammation: no pain, no gain.
    Mocarski ES
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3362-4. PubMed ID: 11904398
    [No Abstract]   [Full Text] [Related]  

  • 8. At the crossroads of inflammation and cancer.
    Clevers H
    Cell; 2004 Sep; 118(6):671-4. PubMed ID: 15369667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer prevention.
    Mokbel K
    Br J Gen Pract; 2002 Dec; 52(485):972-3. PubMed ID: 12528581
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced expression of cyclooxygenase-2 and prostaglandin E2 in response to endotoxin after trauma is dependent on MAPK and NF-kappaB mechanisms.
    Yan Z; Stapleton PP; Freeman TA; Fuortes M; Daly JM
    Cell Immunol; 2004; 232(1-2):116-26. PubMed ID: 15890324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.
    Klein RD; Van Pelt CS; Sabichi AL; Dela Cerda J; Fischer SM; Fürstenberger G; Müller-Decker K
    Cancer Res; 2005 Mar; 65(5):1808-13. PubMed ID: 15753378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenases and central nervous system inflammation: conceptual neglect of cyclooxygenase 1.
    Schwab JM; Schluesener HJ
    Arch Neurol; 2003 Apr; 60(4):630-2. PubMed ID: 12707082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Central role of epidermic growth factor receptor (EGFR) in hypertrophic gastropathy and cancer of the colon].
    Desreumaux P
    Gastroenterol Clin Biol; 2002; 26(6-7):648-9. PubMed ID: 12193872
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways.
    Ogunwobi OO; Beales IL
    Regul Pept; 2006 Mar; 134(1):1-8. PubMed ID: 16169610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.
    Kang S; Kim YB; Kim MH; Yoon KS; Kim JW; Park NH; Song YS; Kang D; Yoo KY; Kang SB; Lee HP
    Cancer Lett; 2005 Jan; 217(1):11-6. PubMed ID: 15596291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators.
    Wu KK
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):89-93. PubMed ID: 15626591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer?
    Assenat E; Gerbal-chaloin S; Maurel P; Vilarem MJ; Pascussi JM
    Eur J Cancer; 2006 Apr; 42(6):785-92. PubMed ID: 16510279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors.
    Kubis N; Levy BI
    J Mol Cell Cardiol; 2004 Mar; 36(3):331-2. PubMed ID: 15010271
    [No Abstract]   [Full Text] [Related]  

  • 19. First results for agents targeting cancer-related inflammation.
    Garber K
    J Natl Cancer Inst; 2009 Aug; 101(16):1110-2. PubMed ID: 19671776
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicine. Estrogen's ties to COX-2 may explain heart disease gender gap.
    Couzin J
    Science; 2004 Nov; 306(5700):1277. PubMed ID: 15550635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.